Viewing Study NCT02828657


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2026-03-04 @ 9:36 PM
Study NCT ID: NCT02828657
Status: COMPLETED
Last Update Posted: 2020-07-13
First Post: 2016-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ORBERA™ Post-Approval Study
Sponsor: Apollo Endosurgery, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: OPAS-1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators